Status of and perspectives on COVID-19 vaccination after lifting of the dynamic zero-COVID policy in China
暂无分享,去创建一个
[1] Kenji Karako,et al. Trends in managing COVID-19 from an emerging infectious disease to a common respiratory infectious disease: What are the subsequent impacts on and new challenges for healthcare systems? , 2022, Bioscience trends.
[2] Y. Bozkuş,et al. Menstrual Changes after COVID-19 Infection and COVID-19 Vaccination , 2022, International journal of clinical practice.
[3] R. Bednarczyk,et al. Vaccine Attitudes and COVID-19 Vaccine Intention Among Parents of Children With Kidney Disease or Primary Hypertension , 2022, American Journal of Kidney Diseases.
[4] M. Waselewski,et al. Perceptions of COVID-19 Vaccine Incentives Among Adolescents and Young Adults , 2022, JAMA network open.
[5] Yuanhong Liu,et al. COVID-19 Vaccine Hesitancy Among Older Adolescents and Young Adults: A National Cross-Sectional Study in China , 2022, Frontiers in Public Health.
[6] D. Goldblatt. SARS-CoV-2: from herd immunity to hybrid immunity , 2022, Nature Reviews Immunology.
[7] W. Sage,et al. Reducing "COVID-19 Misinformation" While Preserving Free Speech. , 2022, JAMA.
[8] Madhavrao D. Chavan,et al. Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review , 2022, Journal of medical virology.
[9] Cassondra Marshall,et al. Predictors of COVID-19 Vaccination Likelihood Among Reproductive-Aged Women in the United States , 2022, Public health reports.
[10] Chao Zhang,et al. Molecular basis of receptor binding and antibody neutralization of Omicron , 2022, Nature.
[11] S. Schrag,et al. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants. , 2022, JAMA.
[12] K. Khunti,et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection , 2021, Nature Medicine.
[13] Jiahao Wang,et al. Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study , 2021, Vaccines.
[14] Céline Darnon,et al. Economic insecurity and compliance with the COVID‐19 restrictions , 2021, European journal of social psychology.
[15] Yankun Zhang,et al. Effects of COVID-19 and mRNA vaccines on human fertility , 2021, Human reproduction.
[16] S. Bolotin,et al. Achieving and sustaining herd immunity to SARS-CoV-2 , 2021, Canadian Medical Association Journal.
[17] L. Suggs,et al. Willingness to vaccinate against Covid-19: A qualitative study involving older adults from Southern Switzerland , 2021, Vaccine: X.
[18] P. Austin,et al. Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study , 2021, BMJ.
[19] Kate C Prickett,et al. COVID-19 Vaccine Hesitancy and Acceptance in a Cohort of Diverse New Zealanders , 2021, The Lancet Regional Health - Western Pacific.
[20] A. Ströhle,et al. COVID-19 vaccine hesitancy and related fears and anxiety , 2021, International Immunopharmacology.
[21] C. Nunes,et al. Factors Associated with COVID-19 Vaccine Hesitancy , 2021, Vaccines.
[22] A. Milstein,et al. Influence of a COVID-19 vaccine’s effectiveness and safety profile on vaccination acceptance , 2021, Proceedings of the National Academy of Sciences.
[23] Hongjie Yu,et al. The determinants of vaccine hesitancy in China: A cross-sectional study following the Changchun Changsheng vaccine incident. , 2020, Vaccine.
[24] Zhènglì Shí,et al. Characteristics of SARS-CoV-2 and COVID-19 , 2020, Nature Reviews Microbiology.
[25] M. Agha,et al. The socio-economic implications of the coronavirus pandemic (COVID-19): A review , 2020, International Journal of Surgery.
[26] B. Renner,et al. Predicting vaccination using numerical and affective risk perceptions: the case of A/H1N1 influenza. , 2012, Vaccine.
[27] C. Mandl,et al. Vaccines for the twenty-first century society , 2011, Nature Reviews Immunology.
[28] K. Choi,et al. Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population , 2010, Vaccine.